FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323565590> ?p ?o ?g. }

• W4323565590 endingPage "112" @default.
• W4323565590 startingPage "112" @default.
• W4323565590 abstract "Background—Coronary endarterectomy (CEA) has been introduced to allow revascularization in end-stage coronary artery disease (CAD). After CEA, the injured remnants of the vessel’s media could result in fast neo intimal tissue ingrowth, which require an anti-proliferation agent (antiplatelet therapy (APT). We aimed to review outcomes of patients undergoing CEA within bypass surgery who received either single-APT (SAPT) or dual-APT (DAPT). Methods—We retrospectively evaluated 353 consecutive patients undergoing CEA within isolated coronary artery bypass grafting (CABG) in the period 01/2000–07/2019. After surgery, patients received either SAPT (n = 153), or DAPT (n = 200) for six months then lifelong SAPT. Endpoints included early, late survival, and freedom from major-adverse-cardiac and cerebrovascular events (MACCE), which were defined as incidence of stroke, myocardial infarction, need for coronary intervention (PCI or CABG) or death for any cause. Results—Patients’ mean age was 67 ± 9.3 years; they were predominantly male 88.1%. Both DAPT- and SAPT-groups had the same extent of CAD (mean SYNTAX-Score-II: 34.1 ± 11.6 vs. 34.4 ± 17.2, p = 0.91). Postoperatively, no difference between DAPT- and SAPT-groups was reported in the incidence of low-cardiac-output syndrome (5% vs. 9.8%, p = 0.16), revision for bleeding (5% vs. 6.5% p = 0.64), 30-day mortality (4.5% vs. 5.2%, p = 0.8) or MACCE (7.5% vs. 11.8%, p = 0.19). Imaging follow-up reported significantly higher CEA and total grafts patency (90% vs. 81.5% and 95% vs. 81%, p = 0.017) in DAPT patients. Late outcomes within 97.4 ± 67.4 months show lower incidence of overall mortality (19 vs. 51%, p < 0.001) and MACCE (24.5 vs. 58.2%, p < 0.001) in the DAPT patients when compared with SAPT patients. Conclusions—Coronary endarterectomy allows revascularization in end-stage CAD when the myocardium is still viable. The use of dual APT after CEA for at least six months seems to improve mid-to-long-term patency rates and survival, and reduced the incidence of major adverse cardiac and cerebrovascular events." @default.
• W4323565590 created "2023-03-09" @default.
• W4323565590 creator A5004915706 @default.
• W4323565590 creator A5023857721 @default.
• W4323565590 creator A5027876138 @default.
• W4323565590 creator A5031469882 @default.
• W4323565590 creator A5035620570 @default.
• W4323565590 creator A5036003598 @default.
• W4323565590 creator A5054362427 @default.
• W4323565590 creator A5062418579 @default.
• W4323565590 creator A5067177183 @default.
• W4323565590 creator A5090710276 @default.
• W4323565590 date "2023-03-07" @default.
• W4323565590 modified "2023-09-24" @default.
• W4323565590 title "Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery" @default.
• W4323565590 cites W10034642 @default.
• W4323565590 cites W111766519 @default.
• W4323565590 cites W192738711 @default.
• W4323565590 cites W1975879316 @default.
• W4323565590 cites W1989024645 @default.
• W4323565590 cites W1990632885 @default.
• W4323565590 cites W2001421223 @default.
• W4323565590 cites W2035665005 @default.
• W4323565590 cites W2040868595 @default.
• W4323565590 cites W2041730774 @default.
• W4323565590 cites W2057282705 @default.
• W4323565590 cites W2095631860 @default.
• W4323565590 cites W2117950068 @default.
• W4323565590 cites W2122427048 @default.
• W4323565590 cites W2321204177 @default.
• W4323565590 cites W2327848624 @default.
• W4323565590 cites W2472281470 @default.
• W4323565590 cites W2585654455 @default.
• W4323565590 cites W2617497775 @default.
• W4323565590 cites W2752033985 @default.
• W4323565590 cites W2762383777 @default.
• W4323565590 cites W2810736670 @default.
• W4323565590 cites W2917662561 @default.
• W4323565590 cites W2919503124 @default.
• W4323565590 cites W2940485360 @default.
• W4323565590 cites W4211143229 @default.
• W4323565590 cites W4220920633 @default.
• W4323565590 cites W4310179633 @default.
• W4323565590 cites W4321429407 @default.
• W4323565590 doi "https://doi.org/10.3390/jcdd10030112" @default.
• W4323565590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36975876" @default.
• W4323565590 hasPublicationYear "2023" @default.
• W4323565590 type Work @default.
• W4323565590 citedByCount "0" @default.
• W4323565590 crossrefType "journal-article" @default.
• W4323565590 hasAuthorship W4323565590A5004915706 @default.
• W4323565590 hasAuthorship W4323565590A5023857721 @default.
• W4323565590 hasAuthorship W4323565590A5027876138 @default.
• W4323565590 hasAuthorship W4323565590A5031469882 @default.
• W4323565590 hasAuthorship W4323565590A5035620570 @default.
• W4323565590 hasAuthorship W4323565590A5036003598 @default.
• W4323565590 hasAuthorship W4323565590A5054362427 @default.
• W4323565590 hasAuthorship W4323565590A5062418579 @default.
• W4323565590 hasAuthorship W4323565590A5067177183 @default.
• W4323565590 hasAuthorship W4323565590A5090710276 @default.
• W4323565590 hasBestOaLocation W43235655901 @default.
• W4323565590 hasConcept C126322002 @default.
• W4323565590 hasConcept C127413603 @default.
• W4323565590 hasConcept C141071460 @default.
• W4323565590 hasConcept C164705383 @default.
• W4323565590 hasConcept C2775901492 @default.
• W4323565590 hasConcept C2776820930 @default.
• W4323565590 hasConcept C2778213512 @default.
• W4323565590 hasConcept C2778881276 @default.
• W4323565590 hasConcept C2779464278 @default.
• W4323565590 hasConcept C2779745121 @default.
• W4323565590 hasConcept C2780007028 @default.
• W4323565590 hasConcept C2780400711 @default.
• W4323565590 hasConcept C2780645631 @default.
• W4323565590 hasConcept C45393284 @default.
• W4323565590 hasConcept C500558357 @default.
• W4323565590 hasConcept C71924100 @default.
• W4323565590 hasConcept C78519656 @default.
• W4323565590 hasConceptScore W4323565590C126322002 @default.
• W4323565590 hasConceptScore W4323565590C127413603 @default.
• W4323565590 hasConceptScore W4323565590C141071460 @default.
• W4323565590 hasConceptScore W4323565590C164705383 @default.
• W4323565590 hasConceptScore W4323565590C2775901492 @default.
• W4323565590 hasConceptScore W4323565590C2776820930 @default.
• W4323565590 hasConceptScore W4323565590C2778213512 @default.
• W4323565590 hasConceptScore W4323565590C2778881276 @default.
• W4323565590 hasConceptScore W4323565590C2779464278 @default.
• W4323565590 hasConceptScore W4323565590C2779745121 @default.
• W4323565590 hasConceptScore W4323565590C2780007028 @default.
• W4323565590 hasConceptScore W4323565590C2780400711 @default.
• W4323565590 hasConceptScore W4323565590C2780645631 @default.
• W4323565590 hasConceptScore W4323565590C45393284 @default.
• W4323565590 hasConceptScore W4323565590C500558357 @default.
• W4323565590 hasConceptScore W4323565590C71924100 @default.
• W4323565590 hasConceptScore W4323565590C78519656 @default.
• W4323565590 hasIssue "3" @default.
• W4323565590 hasLocation W43235655901 @default.
• W4323565590 hasLocation W43235655902 @default.

• next